Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



ROGERS MICHAEL W Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 45,000 options to buy @ $1.2, valued at $54k
09/26/2022 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 97,063 options to buy @ $0.9152, valued at $88.8k
06/09/2022 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 13,700 shares @ $0
Granted 20,100 options to buy @ $0.45, valued at $9k
09/13/2021 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 22,812 options @ $3.97, valued at $90.6k
06/03/2021 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 13,700 shares @ $0
Granted 20,100 options to buy @ $3.37, valued at $67.7k
09/17/2020 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 15,024 options @ $5.99, valued at $90k
Granted 14,987 options @ $5.99, valued at $89.8k
06/09/2020 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 13,700 shares @ $0
Granted 20,100 options to buy @ $11.96, valued at $240.4k
06/27/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2019 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 13,700 shares @ $0
Granted 20,100 options to buy @ $4.23, valued at $85k
05/16/2019 4 ROGERS MICHAEL W (See Remarks) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.
Txns: Granted 169,500 options to buy @ $1.04, valued at $176.3k
Granted 430,500 options to buy @ $1.04, valued at $447.7k
02/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/13/2018 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 11,229 shares @ $0
Granted 18,716 options to buy @ $12.48, valued at $233.6k
Granted 11,229 options to buy @ $15.26, valued at $171.4k
Granted 11,229 options to buy @ $17.53, valued at $196.8k
Granted 11,229 options to buy @ $10.05, valued at $112.9k
Granted 25,000 options to buy @ $8.94, valued at $223.5k
12/13/2018 4 ROGERS MICHAEL W (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 30,000 shares @ $0
Disposed/sold 140,000 options @ $0
11/16/2018 4 ROGERS MICHAEL W (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 100,000 options to buy @ $1.13, valued at $113k
07/12/2018 4 ROGERS MICHAEL W (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Granted 10,000 shares @ $0
Granted 30,000 options to buy @ $3.76, valued at $112.8k
06/29/2018 4 ROGERS MICHAEL W (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 12,500 restricted stock units @ $0
06/26/2018 4 ROGERS MICHAEL W (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Granted 26,667 options to buy @ $1.95, valued at $52k
Granted 6,667 restricted stock units @ $0
04/25/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2017 4 ROGERS MICHAEL W (Director) has filed a Form 4 on pSivida Corp.
Txns: Granted 20,000 options to buy @ $1.77, valued at $35.4k
Granted 12,500 restricted stock units @ $0
12/18/2017 4 ROGERS MICHAEL W (CFO) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.
Txns: Granted 293,006 options to buy @ $5.5, valued at $1.6M
06/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/14/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/27/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/13/2016 4 ROGERS MICHAEL W (CFO) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns: Granted 20,000 options to buy @ $26.4, valued at $528k
10/09/2013 4 ROGERS MICHAEL W (CFO) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns: Granted 45,600 shares @ $0
Granted 136,900 options to buy @ $35.91, valued at $4.9M
02/11/2013 4 ROGERS MICHAEL W (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC
12/14/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
02/24/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
12/01/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
12/10/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
11/20/2009 4 ROGERS MICHAEL W (Director) has filed a Form 4 on pSivida Corp.
02/25/2009 4 ROGERS MICHAEL W (Executive Vice President) has filed a Form 4 on INDEVUS PHARMACEUTICALS INC
12/08/2008 4 ROGERS MICHAEL W (Executive Vice President) has filed a Form 4 on INDEVUS PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy